跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,890 条关于
“Orchestra BioMed Holdings”
全部
1,890
临床试验
401
药物
284
机构
239
资讯
966
去年
Orchestra BioMed's BACKBEAT Trial Launch Drives 40% Stock Surge Amid Promising Cardiovascular Pipeline
去年
FDA Grants Breakthrough Device Designation to Orchestra BioMed's AVIM Therapy for Hypertension
去年
Orchestra BioMed Expands BACKBEAT Hypertension Trial Eligibility 24-Fold Following FDA Protocol Approval
去年
Vivasure Medical Secures CE Mark for First Fully Absorbable Large-Bore Vascular Closure System
10个月前
Orchestra BioMed Initiates Pivotal Trial for Novel Sirolimus-Eluting Balloon in Coronary In-Stent Restenosis
去年
Mount Sinai's Dr. Vivek Reddy to Lead Orchestra BioMed's BACKBEAT Study as Executive Chairman
去年
UCB's Minzasolmin Fails Phase 2 ORCHESTRA Trial for Early Parkinson's Disease
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
Windward Bio Launches with $200 Million to Advance Long-Acting Anti-TSLP Antibody for Asthma and COPD
9个月前
Harbour BioMed Expands AstraZeneca Partnership for Next-Generation Oncology Therapeutics
第 1 页,共 97 页
上一页
下一页